6533b831fe1ef96bd1299800

RESEARCH PRODUCT

Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)

D. Lorente EstellesSarai PalancaG. Pérez-simóNuria MancheñoO.j. Juan VidalJ. Gomez CodinaB. LaizJ. SimarroR. Murria

subject

business.industryPcr assayHematologymedicine.diseaseEGFR Tyrosine Kinase Inhibitorslaw.inventionT790MOncologylawMutation (genetic algorithm)medicineCancer researchNon small lung cancerMutation detectionLung cancerbusinessPolymerase chain reactionhttps://doi.org/10.1093/annonc/mdz073.008